Global Cardiology Conference Showcases Breakthroughs in Tricuspid Valve and TAVI Innovations 💡 Punchline: Live Cases. Smart Solutions. Shaping the Future of Structural Heart Therapies. 🩺 Full News: The Global Cardiology Conference opened with an inspiring start, bringing together top cardiac experts, researchers, and innovators from across the world to discuss the latest advancements in structural heart interventions. The event began with a live case demonstration of Tricuspid Valve Intervention by Dr. Krissada Meemook from Ramathibodi Hospital, Bangkok, highlighting advanced procedural skills and real-time clinical excellence. A scientific session led by Dr. Amit Chaurasia focused on the Role of the Bicaval Valve System in the Management of Tricuspid Regurgitation (TR), offering deep insights into how this novel approach can improve outcomes for complex tricuspid valve cases. Adding to the excitement, the Hands-on Training Hub provided participants with a unique opportunity to explore newer technologies in tricuspid regurgitation, including the TricValve Solution and the Vienna Aortic Valve — the world’s only pre-mounted, dry-tissue, ready-to-use TAVI system. The day was marked by innovation, collaboration, and shared learning, setting a strong tone for the future of cardiovascular medicine. Experts emphasized the importance of technological advancements, knowledge exchange, and multidisciplinary teamwork in driving better patient outcomes and redefining standards in structural heart therapy. The conference successfully reflected the spirit of continuous learning and innovation — uniting the global cardiology community to advance the frontiers of heart care.